Gleamer
About Gleamer
Gleamer is a French medtech company, founded in 2017, specializing in artificial intelligence (AI) solutions for medical imaging. The company’s core mission is to empower radiologists and clinicians by enhancing diagnostic accuracy and efficiency while simultaneously reducing their workload. Gleamer’s innovative platform, known as the “Gleamer Copilot®,” offers semi-automated pre-diagnosis of medical images, facilitating the detection of pathologies and the generation of reliable, structured reports across various imaging modalities, including X-ray, CT, Mammography, and MRI. These AI solutions are deployed in over 2,500 institutions across 45 countries, processing more than 35 million examinations annually, with the aim of improving patient care, accelerating treatments, optimizing workflows, and reducing healthcare costs.
In March 2026, Gleamer was acquired by RadNet, Inc., a U.S. leader in outpatient diagnostic imaging services, for $269.3 million (or €230 million) in an all-cash transaction. Gleamer is now integrated into DeepHealth, RadNet’s wholly-owned subsidiary, a move that establishes DeepHealth as the largest provider of radiology clinical AI solutions worldwide. This acquisition is anticipated to drive significant cost efficiencies and enhance patient care within RadNet’s network by the third quarter of 2026. Gleamer’s technology is particularly noted for its leadership in routine imaging, especially X-ray, and its capabilities in automated exam prioritization and draft reporting are expected to reengineer high-volume workflows and accelerate diagnostic delivery.
What Physicians Need to Know
Gleamer's AI tools are designed to be your 'copilot' in radiology, significantly boosting diagnostic accuracy and efficiency. Expect faster reading times, reduced risk of missing subtle findings, and automated reporting that frees you to focus on complex cases and patient care. Its comprehensive coverage across modalities and clinical areas, combined with robust clinical validation, provides a reliable safety net, especially in high-volume or emergency settings. The seamless integration into existing workflows means minimal disruption and maximum benefit to your daily practice.
Gleamer's solutions, including the 'Gleamer Copilot' and 'Gleamer OS,' are built for seamless integration into existing radiology workflows. They connect effortlessly with PACS/RIS systems via a single gateway, allowing for advanced workflows like worklist prioritization and shadow mode. The cloud-native architecture ensures scalable, secure (HIPAA, GDPR compliant), and resilient deployment, with zero-footprint AI analysis where data remains within your environment.
What the Web Says
Gleamer is a medical imaging software company that utilizes AI to enhance the analysis and diagnosis of medical images, particularly X-rays. The company's products, such as BoneView and ChestView, are designed to assist healthcare professionals, especially radiologists and emergency physicians, in detecting anomalies like fractures, effusions, dislocations, and lung pathologies. Gleamer's AI aims to improve diagnostic accuracy, reduce human error, and increase efficiency in medical imaging workflows. It has received FDA clearance for its ChestView product and is recognized as an innovative tool in the healthcare IT sector.
Overall: MixedStrengths
- Improved diagnostic accuracy and speed through AI-powered algorithms.
- Intuitive and user-friendly interface.
- Seamless integration with existing medical imaging systems.
- Ability to detect various pathologies across different imaging modalities (X-rays, MRIs, CT scans).
- Features like worklist prioritization and automated reporting.
- Potential to enhance patient care, especially in emergency settings with radiologist shortages.
Limitations
- High initial investment in software and hardware infrastructure.
- Potential for algorithmic bias in training data affecting specific patient populations.
- Risk of over-reliance on AI leading to deskilling of radiologists.
- Data privacy and security concerns when sharing sensitive patient data.
- The 'black box' nature of some AI algorithms can hinder understanding and trust.
- Some Reddit users report instances of AI detecting 'ghost fractures' or being wrong frequently.
Based on reviews from: ITQlick, SoftwareWorld, Elion Health, Gleamer (Official Website), Indeed.com (for 'The Gleamery' and 'Gleam' - note: these appear to be different companies), Reddit, G2 (for 'GleamHR' and 'Glean' - note: these appear to be different companies), Capterra (for 'Gleam Apps' and 'GleamHR' - note: these appear to be different companies), BioWorld, PMC (PubMed Central)
Last updated: 2026-07-19
Videos
News, demos, and interviews about Gleamer.
Videos load interactively. If none appear, search YouTube for Gleamer →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Gleamer.
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]